3M Acquires VC-Backed Acolyte

3M (NYSE: MMM) has acquired Acolyte Biomedica Ltd., a Salisbury, UK-based provider of an automated microbial detection platform for the detection, diagnosis and treatment of infectious diseases. The all-cash deal included various earnouts, although specific terms were not disclosed. Acolyte had raised VC funding from ANGLE Technology Group and Circus Capital. www.3m.com www.acolytebiomedica.com